By 2020, the pharmaceutical market is anticipated to more than double to $1.3 trillion U.S. dollars. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.
Pharma companies face a number of key decisions that will determine their success and even survival in a dramatically changing global environment. Customers are demanding value defined by both outcome and cost effectiveness. Scientific discovery and medicine are undergoing a data-driven and genetically informed revolution that shifts focus from mass-market to individualized treatment.
Those that successfully adapt will be able to tap into a rapidly growing global market focused on preventing and managing illness, bottom-of-the-pyramid solutions, and integrated health management approaches that combine pharmaceuticals with mobile communications, diagnosis, and monitoring.